AbbVie | ABBV - Spese Di Vendita E Di Amministrazione

Prezzo Delle Azioni
198.71
Cambio Giornaliero
-2.24 -1.11%
Mensile
-4.09%
Annuale
6.80%
Q2 Previsione
194.46




Spese Di Vendita E Di Amministrazione Cambiamento Data
AbbVie USD 3.89B 325M 2025-12
Abbott USD 3.27B 138M 2026-03
ALKERMES USD 187.2M 15.43M 2025-12
Amgen USD 1.94B 237M 2025-12
AstraZeneca USD 4.61B 4.46B 2025-12
Biogen USD 545.2M 38.6M 2025-09
BioMarin Pharmaceutical USD 322.21M 98.79M 2025-12
Bristol-Myers Squibb USD 2.18B 392M 2025-12
Coherus Biosciences USD 15M 6.26M 2025-12
Eisai JPY 111.72B 7.86B 2025-12
Eli Lilly USD 3.13B 391.3M 2025-12
Gilead Sciences USD 1.78B 425M 2025-12
GlaxoSmithKline GBP 2.68B 518M 2025-12
Infinity Pharmaceuticals USD 3.75M 2.19M 2023-06
J&J USD 6.03B 719M 2026-03
Medtronic 2.97B 159M 2025-09
Merck USD 2.85B 215M 2025-12
Neurocrine Biosciences USD 301.8M 10.2M 2025-12
Novartis USD 3.44B 128M 2025-12
Pacira USD 91.87M 70K 2025-12
Perrigo USD 255.9M 10.2M 2025-12
Pfizer USD 4.08B 894M 2025-12
Regeneron Pharmaceuticals USD 775M 117.2M 2025-12
Roche Holding CHF 7.28B 3.99B 2025-12
Sanofi EUR 2.33B 419M 2026-03
UCB EUR 1.47B 193M 2025-12
Ultragenyx Pharmaceutical USD 89M 2.38M 2025-12
United Therapeutics USD 190.6M 38.6M 2025-12
Vertex Pharmaceuticals USD 487M 41.9M 2025-12
Zoetis USD 619M 40M 2025-12